LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-14,19 % | 11,52 Mrd. | |
+44,16 % | 3,27 Mrd. | |
-19,90 % | 2,02 Mrd. | |
-38,37 % | 2,03 Mrd. | |
-30,21 % | 1,44 Mrd. | |
+16,18 % | 1,01 Mrd. | |
-6,11 % | 719 Mio. | |
-32,75 % | 418 Mio. | |
-52,35 % | 339 Mio. |